Legato Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.64M	Sell	6,004 -2,799	-32%	-$2.14M	0.42%	37
2025 Q4	$6.79M	Sell	8,803 -1,400	-14%	-$951K	0.58%	20
2025 Q3	$5.74M	Buy	10,203 +419	+4%	+$237K	0.62%	24
2025 Q2	$5.14M	Hold	9,784	–	–	0.61%	27
2025 Q1	$6.21M	Buy	9,784 +5,277	+117%	+$3.63M	0.84%	9
2024 Q4	$3.21M	Buy	4,507 +411	+10%	+$345K	0.42%	35
2024 Q3	$4.31M	Sell	4,096 -298	-7%	-$332K	0.53%	23
2024 Q2	$4.62M	Sell	4,394 -1,301	-23%	-$1.26M	0.62%	19
2024 Q1	$5.48M	Buy	5,695 +200	+4%	+$190K	0.66%	18
2023 Q4	$4.83M	Hold	5,495	–	–	0.63%	25
2023 Q3	$4.52M	Hold	5,495	–	–	0.66%	22
2023 Q2	$3.95M	Hold	5,495	–	–	0.53%	32
2023 Q1	$4.52M	Hold	5,495	–	–	0.82%	10
2022 Q4	$3.96M	Buy	+5,495	New	+$4.05M	0.76%	11
2021 Q3	–	Sell	-2,793	Closed	-$1.56M	–	289
2021 Q2	$1.56M	Buy	+2,793	New	+$1.41M	0.22%	108